Efficacy of Omadacycline-Containing Regimen in a Mouse Model of Pulmonary Mycobacteroides abscessus Disease

por Rimal, Binayak, Nicklas, Danielle A., Panthi, Chandra M., Lippincott, Christopher K., Belz, Daniel C., Ignatius, Elisa H., Deck, Daniel H., Serio, Alisa W., Lamichhane, Gyanu
Publicado 2023

Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis

por Ignatius, Elisa H, Wang, Kunbo, Karaba, Andrew, Robinson, Matthew, Avery, Robin K, Blair, Paul, Chida, Natasha, Jain, Tania, Petty, Brent G, Siddiqui, Zishan, Melia, Michael T, Auwaerter, Paul G, Xu, Yanxun, Garibaldi, Brian T
Publicado 2020

Reply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis

por Dooley, Kelly E., Miyahara, Sachiko, von Groote-Bidlingmaier, Florian, Sun, Xin, Hafner, Richard, Rosenkranz, Susan L., Ignatius, Elisa H., Nuermberger, Eric L., Moran, Laura, Donahue, Kathleen, Swindells, Susan, Vanker, Naadira, Diacon, Andreas H.
Publicado 2020

Nebulized Bacteriophage in a Patient With Refractory Mycobacterium abscessus Lung Disease

por Dedrick, Rebekah M, Freeman, Krista G, Nguyen, Jan A, Bahadirli-Talbott, Asli, Cardin, Mitchell E, Cristinziano, Madison, Smith, Bailey E, Jeong, Soowan, Ignatius, Elisa H, Lin, Cheng Ting, Cohen, Keira A, Hatfull, Graham F
Publicado 2022